Void · Coders disagree
Rules 1.1.0 · as of 14 Sep 2026
Owen Scott Muir · Said 26 Jun 2024 · owen-1137
Quote
“To put my dime down, I don't think MDMA-AT will be approved by the FDA when it meets to discuss the 10-1 and 9-2 against AdComm votes cautioning against approval of the combination product at this time.”
The author's headline call in the seventh 'Saving MDMA' article: the FDA will not approve Lykos Therapeutics' NDA for MDMA-assisted therapy at the pending decision, following the June 2024 AdComm votes of 10-1 and 9-2 against. Post dated 2024-06-26, before the FDA action date.